Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Devopharma ApS
APS
Active
Advertising protection
CVR 38968254
Strandvejen 301, 2920
Charlottenlund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Devopharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
AA
Allan Anesteen Tharuman
Founder
Founder
2017
HN
Henrik Nakskov
Management
Management
2017
SL
Søren Luplau-Pagh
Management
Management
2017
Former (1)
MO
Morten Olesen
Management
Management
2017 – 2019
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
HN HOLDING 2010 ApS — 50–66.65%
Friendly Holding ApS — 25–33.32%
JARCO HOLDING ApS — 15–19.99%
GAIN ApS — 10–14.99%
Allan Anesteen Tharuman — 20–24.99%
Stephan Dr Braun — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
HN HOLDING 2010 ApS
Company
50–66.65%
50–66.65%
2017
Friendly Holding ApS
Company
25–33.32%
25–33.32%
2017
JARCO HOLDING ApS
Company
15–19.99%
15–19.99%
2026
GAIN ApS
Company
10–14.99%
10–14.99%
2026
Allan Anesteen Tharuman
Individual
20–24.99%
20–24.99%
2017
Stephan Dr Braun
Individual
25–33.32%
25–33.32%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Devopharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
